‹ All stocks
Translational Development Acquisition Corp.
TDACW · NASDAQ · Financial Services
$1.40
▲ $1.40 (330.77%)
Day range
$0.33 – $1.50
Year range
$0.06 – $2.80
Open
$0.33
Previous close
—
Market cap
$209.79M
Volume (24h)
$1.2K
Volume (52w)
$1.74K
Performance
7D
▼ -6.67%
1M
▼ -24.32%
3M
▼ -4.76%
6M
▲ 656.76%
1Y
▲ 382.76%
YTD
▲ 351.61%
3Y
▲ 399.29%
5Y
▲ 399.29%
All-time
▲ 399.29%
Key statistics
P/E ratio
—
EPS (TTM)
—
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
149.8M
About Translational Development Acquisition Corp.
Translational Development Acquisition Corp., established in 2022 and headquartered in New York, New York, currently possesses no significant business operations. Its primary objective is to finalize a strategic business combination, which could involve a merger, share exchange, asset acquisition, or reorganization, with one or more other entities.
Visit websiteCountry: United States of America
More in Financial Services
BRK-B Berkshire Hathaway |
$500.50 | 0.51% |
JPM JPMorgan Chase & Co. |
$333.18 | 0.71% |
V Visa |
$359.85 | 0.14% |
MA Mastercard Incorporated |
$550.00 | -0.27% |
BAC Bank of America |
$53.73 | -1.29% |